Actively Recruiting

Age: 18Years +
All Genders
NCT07531966

Vascular Complications After Kidney Transplantation

Led by University of Aarhus · Updated on 2026-04-15

60

Participants Needed

3

Research Sites

260 weeks

Total Duration

On this page

Sponsors

U

University of Aarhus

Lead Sponsor

A

Aarhus University Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

* To determine the incidence of arterial inflow problems and venous outflow problems as causes of impaired renal function and/or treatment-resistant hypertension after kidney transplantation, when all kidney-transplant recipients in Denmark are evaluated according to uniform, well-defined clinical criteria. * To investigate the efficacy and safety of catheter-based balloon treatment (percutaneous transluminal angioplasty, PTA) for these vascular complications, of which transplant renal artery stenosis is by far the most common. * To assess whether novel imaging and functional diagnostic methods can predict treatment response.

CONDITIONS

Official Title

Vascular Complications After Kidney Transplantation

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Have impaired kidney function after transplant, defined by acute drop in kidney filtration rate, low filtration rate 30 days post-transplant, or decline after certain blood pressure medications
  • Have persistent resistant hypertension for more than 6 weeks after transplant despite treatment with at least three types of blood pressure medications
  • Show at least one radiological sign of artery narrowing by CT, MR angiography, or Doppler ultrasound
  • Confirmed stenosis of 70% or more, or 50-69% with specific pressure gradient criteria
  • Able to provide informed consent
Not Eligible

You will not qualify if you...

  • Unable to give informed consent
  • Have active rejection of the kidney transplant requiring treatment
  • Pregnant
  • Have had balloon angioplasty (PTA) on the same vessel before
  • Cannot tolerate any blood clot prevention therapy and so cannot receive stents

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Aarhus University Hospital

Aarhus, Denmark, 8200

Actively Recruiting

2

Rigshospitalet

Copenhagen, Denmark, 2100

Actively Recruiting

3

Odense University Hospital

Odense, Denmark, 5000

Actively Recruiting

Loading map...

Research Team

M

Mark Reinhard, MD, PhD

CONTACT

H

Henrik Birn, MD, DMSc

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here